• Alnounou M, Munoz SJ 2006 Nutrition Issues In Gastroenterology, Series #37. Nutrition concerns of the patient with primary biliary cirrhosis or primary sclerosing cholangitis. [http://www.healthsystem.virginia.edu/internet/digestive-health/nutritionarticles/April2006.pdf] Practical Gastroenterology April 2006: 92-100. *

• Balistreri WF 2003 Genetic liver disease. 54th Annual Meeting of the American Association for the Study of Liver Diseases.

• Balzer K, Hotz J, Goebell H 1980 Eosinophilia as a diagnostic clue to primary sclerosing cholangitis. Z. Gastroenterol. 18: 89-93.

• Barnes DS 2002 Intrahepatic cholestatic liver disease. http://www.clevelandclinicmeded.com/diseasemanagement/gastro/intrahepatic/intrahepatic1.htm.

• Benett I, Salh B, Haboubi NY, Braganza JM 1989 Sclerosing cholangitis with hepatic microvesicular steatosis in cystic fibrosis and chronic pancreatitis. J. Clin. Pathol. 42: 466-469. *

• Blackstone MO, Nemchausky BA 1978 Cholangiographic abnormalities in ulcerative colitis associated pericholangitis which resemble sclerosing cholangitis. Am. J. Dig. Dis. 23: 579-585.

• Bornman PC, Lemmer ER, Robson SC, Wright JP, Girdwood AH 1993 Asymptomatic primary sclerosing cholangitis in association with inflammatory bowel disease. J. Clin. Gastroenterol. 16: 263-264.

• Broome U 2003 Autoimmune hepatitis and overlap syndromes. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 38-39. September 12 - 13. *

• Chapman RW 2003 The management of primary sclerosing cholangitis. Curr. Gastroenterol. Rep. 5: 9-17.

• Chapman RW, Arborgh BA, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, Sherlock S 1980 Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 21: 870-877. *

• Chapman RW, Burroughs AK, Bass NM, Sherlock S 1981 Long-standing asymptomatic primary sclerosing cholangitis: report of three cases. Dig. Dis. Sci. 26: 778-782.

• Clements D, Rhodes JM, Elias E 1986 Severe bile duct lesions without biochemical evidence of cholestasis in a case of sclerosing cholangitis. J. Hepatol. 3: 72-74.

• Cox KL, Cox KM 1998 Oral vancomycin: treatment of primary sclerosing cholangitis in children with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 27: 580-583.

• Czaja AJ 2004 Autoimmune hepatitis: clinical and laboratory diagnosis. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 52-54. *

• Czaja AJ 2006 Autoimmune hepatitis - approach to diagnosis. MedGenMed. 8: 55.

• D'Souza-Gburek SM, Batts KP, Nikias GA, Wiesner RH, Krom RA 1997 Liver transplantation for jejunoileal bypass-associated cirrhosis: allograft histology in the setting of an intact bypassed limb. Liver Transpl. Surg. 3: 23-27.

• Das KM 2004 Immunopathogenesis of primary sclerosing cholangitis: possible role of a shared colonic and biliary epithelial antigen. J. Gastroenterol. Hepatol. 19: S290-S294. *

• Delle Monache M, Salvio A, Fiocca F, Basoli A, Ricci GL 1992 Primary sclerosing cholangitis: an analysis of 37 retrospective cases. Ital. J. Gastroenterol. 24: 485-488.

• Der G, Love T, Schreck J, Horn M 2005 Primary sclerosing cholangitis: a case presentation. Gastroenterol. Nurs. 28: 13-16. *

• Durieu I, Pellet O, Simonot L, Durupt S, Bellon G, Durand DV, Minh VA 1999 Sclerosing cholangitis in adults with cystic fibrosis: a magnetic resonance cholangiographic prospective study. J. Hepatol. 30: 1052-1056. *

• Escorsell A, Pares A, Rodes J, Solis-Herruzo JA, Miras M, de la Morena E 1994 Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver. J. Hepatol. 21: 787-791.

• Feld J, Heathcote E 2003 Epidemiology of autoimmune liver disease. J. Gastroenterol. Hepatol. 18: 1118-1128. *

• Franco J, Saeian K 1999 Biliary tract inflammatory disorders: primary sclerosing cholangitis and primary biliary cirrhosis. Curr. Gastroenterol. Rep. 1: 95-101.

• Frederiksen SL, Chen W 2004 D-penicillamine for primary sclerosing cholangitis. Cochrane Database Syst. Rev. 2: CD004182. *

• Friess H, Holzinger F, Liao Q, Buchler MW 2001 Surveillance of pre-malignant disease of the pancreatico-biliary system. Best Pract. Res. Clin. Gastroenterol. 15: 285-300. *

• Gohlke F, Lohse AW, Dienes HP, Lohr H, Marker-Hermann E, Gerken G, Meyer zum Buschenfelde KH 1996 Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis. J. Hepatol. 24: 699-705. *

• Gross JB Jr, Kumar N 2003 Simultaneous occurrence of PSC and MS in a patient. Dig. Dis. Sci. 48: 1397. *

• Hardy RG, Meltzer SJ, Jankowski JA 2000 ABC of colorectal cancer. Molecular basis for risk factors. BMJ 321: 886-889. *

• Hayashi H, Higuchi T, Ichimiya H, Hishida N, Sakamoto N 1990 Asymptomatic primary sclerosing cholangitis treated with ursodeoxycholic acid. Gastroenterology 99: 533-535.

• Helzberg JH, Petersen JM, Boyer JL 1987 Improved survival with primary sclerosing cholangitis. A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients. Gastroenterology 92: 1869-1875.

• Holstege A, Zolinski P, Woidy L, Permanetter W 2007 The patient with unexplained elevated serum liver enzymes. Best Pract. Res. Clin. Gastroenterol. 21: 535-550.

• Hurlburt KJ, McMahon BJ, Deubner H, Hsu-Trawinski B, Williams JL, Kowdley KV 2002 Prevalence of autoimmune liver disease in Alaska Natives. Am. J. Gastroenterol. 97: 2402-2407. *

• Kawai H, Aoyagi Y, Nomoto M, Takizawa H, Suzuki Y, Hama A, Suda T, Takahashi T, Asakura H 2000 Asymptomatic primary sclerosing cholangitis with marked hepatic fibrosis. Dig. Dis. Sci. 45: 680-684. *

• Keeffe EB 1989 Diagnosis of primary sclerosing cholangitis in a blood donor with elevated serum alanine aminotransferase. Gastroenterology 96: 1358-1359.

• Kita R, Kita-Sasai Y, Hanaoka I, Kimura T, Kokuryu H, Takamatsu S, Osaki Y, Tomono N, Hachiya T, Shimizu T 2002 Beneficial effect of bezafibrate on primary sclerosing cholangitis (three case reports). Am. J. Gastroenterol. 97: 1849-1851. *

• Knox TA, Kaplan MM 1991 Treatment of primary sclerosing cholangitis with oral methotrexate. Am. J. Gastroenterol. 86: 546-552.

• Kumagi T, Alswat K, Hirschfield GM, Heathcote J 2008 New insights into autoimmune liver diseases. Hepatol. Res. 38: 745-761. *

• Kurtovic J, Riordan S 2003 Clinical aspects of primary biliary cirrhosis. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 31-32. October 15-16. *

• LaRusso NF, Wiesner RH, Ludwig J, MacCarty RL 1984 Current concepts. Primary sclerosing cholangitis. N. Engl. J. Med. 310: 899-903.

• Lazaridis KN, Lindor KD 1999 Primary biliary cirrhosis. Curr. Treat. Options Gastroenterol. 2: 473-480.

• Levy C, Lindor KD 2003 Current management of primary biliary cirrhosis and primary sclerosing cholangitis. J. Hepatol. 38: S24-S37. *

• Levy C, Lindor KD 2003 Treatment options for primary biliary cirrhosis and primary sclerosing cholangitis. Curr. Treat. Options Gastroenterol. 6: 93-103.

• Levy C, Lindor KD 2006 Primary sclerosing cholangitis: epidemiology, natural history, and prognosis. Semin. Liver Dis. 26: 22-30. *

• Lillemoe KD, Pitt HA, Cameron JL 1990 Primary sclerosing cholangitis. Surg. Clin. North Am. 70: 1381-1402.

• Maier KP 2005 The patient with slightly increased liver function tests. Schweiz. Rundsch. Med. Prax. 94: 139-143.

• Martin M 1993 Primary sclerosing cholangitis. Annu. Rev. Med. 44: 221-227. *

• Matsuhashi N, Ohnishi S, Aburatani H, Sugano K, Imawari M, Takaku F, Konishi F 1989 A case of asymptomatic intrahepatic primary sclerosing cholangitis associated with atypical ulcerative colitis. Nippon Shokakibyo Gakkai Zasshi 86: 793-797.

• Mikkola K, Kiviluoto T, Riihela M, Taavitsainen M, Jarvinen HJ 1995 Liver involvement and its course in patients operated on for ulcerative colitis. Hepatogastroenterology 42: 68-72.

• Morisco F, Pagliaro L, Caporaso N, Bianco E, Sagliocca L, Fargion S, Smedile A, Salvagnini M, Mele A 2008 Consensus recommendations for managing asymptomatic persistent non-virus non-alcohol related elevation of aminotransferase levels: suggestions for diagnostic procedures and monitoring. Dig. Liver Dis. 40: 585-598.

• Munoz SJ, Heubi JE, Balistreri WF, Maddrey WC 1989 Vitamin E deficiency in primary biliary cirrhosis: gastrointestinal malabsorption, frequency and relationship to other lipid-soluble vitamins. Hepatology 9: 525-531.

• Nishio A, Keeffe EB, Gershwin ME 2002 Immunopathogenesis of primary biliary cirrhosis. Semin. Liver Dis. 22: 291-302. *

• Paine P, Hobday C, Keating JJ, Brown CM, Morris JA 2001 Ulcerative pan-colitis and primary sclerosing cholangitis with hyposplenism complicated by fatal pneumococcal meningitis. CME Gastroenterology 4: 95-96. *

• Papachristou GI, Demetris AJ, Craig F, Lee KKW, Rabinovitz M 2004 Cholestatic jaundice and bone lesions in an elderly woman. Nat. Clin. Pract. Gastroenterol. Hepatol. 1: 53-57. *

• Porayko MK, Wiesner RH, LaRusso NF, Ludwig J, MacCarty RL, Steiner BL, Twomey CK, Zinsmeister AR 1990 Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease. Gastroenterology 98: 1594-1602.

• Prall RT, Lindor KD, Wiesner RH, LaRusso NF 2000 Current therapies and clinical controversies in the management of primary sclerosing cholangitis. Curr. Gastroenterol. Rep. 2: 99-103.

• Riestra S, Fernandez E, Rodrigo L 1999 Liver involvement in coeliac disease. Rev. Esp. Enferm. Dig. 91: 846-852.

• Scalone O, Bonaventure C, Pasquier D, Faucheron JL 2003 Should liver biopsy be systematic during surgery for ulcerative colitis? Gastroenterol. Clin. Biol. 27: 94-99.

• Schreibman I, Regev A 2006 Recurrent primary biliary cirrhosis after liver transplantation - the disease and its management. MedGenMed. 8: 30.

• Schrumpf E, Abdelnoor M, Fausa O, Elgjo K, Jenssen E, Kolmannskog F 1994 Risk factors in primary sclerosing cholangitis. J. Hepatol. 21: 1061-1066.

• Schrumpf E, Boberg KM 2002 Endoscopic treatment for primary sclerosing cholangitis? J. Hepatol. 36: 278-279. *

• Shaked A, Colonna JO, Goldstein L, Busuttil RW 1992 The interrelation between sclerosing cholangitis and ulcerative colitis in patients undergoing liver transplantation. Ann. Surg. 215: 598-603. *

• Sorbi D, McGill DB, Thistle JL, Therneau TM, Henry J, Lindor KD 2000 An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities. Am. J. Gastroenterol. 95: 3206-3210. *

• Steele IL, Levy C, Lindor KD 2007 Primary sclerosing cholangitis - approach to diagnosis. MedGenMed. 9: 20.

• Strandvik B, Hjelte L, Gabrielsson N, Glaumann H 1988 Sclerosing cholangitis in cystic fibrosis. Scand. J. Gastroenterol. Suppl. 143: 121-124.

• Strassburg CP 2005 Autoimmune liver diseases. Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, pp. 66-70. *

• Summerfield JA 1983 Primary sclerosing cholangitis. Postgrad. Med. J. 59 Suppl. 4: 99-105.

• Theal RM, Scott K 1996 Evaluating asymptomatic patients with abnormal liver function test results. Am. Fam. Physician 53: 2111-2119.

• Tischendorf JJ, Meier PN, Schneider A, Manns MP, Kruger M 2007 Transpapillary intraductal ultrasound in the evaluation of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Scand. J. Gastroenterol. 42: 1011-1017. *

• van Erpecum KJ, van Berge Henegouwen GP 1989 Hepatobiliary abnormalities in inflammatory bowel disease. Neth. J. Med. 35 Suppl. 1: S40-S49.

• van Milligen de Wit AW, Rauws EA, van Bracht J, Mulder CJ, Jones EA, Tytgat GN, Huibregtse K 1997 Lack of complications following short-term stent therapy for extrahepatic bile duct strictures in primary sclerosing cholangitis. Gastrointest. Endosc. 46: 344-347.

• van Milligen de Wit AW, van Bracht J, Rauws EA, Jones EA, Tytgat GN, Huibregtse K 1996 Endoscopic stent therapy for dominant extrahepatic bile duct strictures in primary sclerosing cholangitis. Gastrointest. Endosc. 44: 293-299.

• Venturini I, Cosenza R, Miglioli L, Borghi A, Bagni A, Gandolfo M, Modonesi G, Zeneroli ML 1998 Adult celiac disease and primary sclerosing cholangitis: two case reports. Hepatogastroenterology 45: 2344-2347.

• Versapuech JM, Labayle D, Grange D, Fischer D, Kemeny F, D'Hubert E 1986 Sclerosing cholangitis, chronic pancreatitis and Sjogren's syndrome. Ann. Med. Interne. (Paris) 137: 147-151.

• Wiesner RH, Grambsch P, LaRusso NF, Dickson ER 1988 Is primary sclerosing cholangitis a progressive disease or not? Hepatology 8: 970-972.

• Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, Hunter EB, Fleming TR, Fisher LD, Beaver SJ, LaRusso NF 1989 Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 10: 430-436.

• Worthington J, Chapman R 2006 Primary sclerosing cholangitis. Orphanet J. Rare Dis. 1: 41. *

• Yoshida Y, Takeuchi K, Nakajima M, Fukuchi S, Unakami M 1987 A case of ulcerative colitis associated with asymptomatic primary sclerosing cholangitis, the lesion of which extends from intrahepatic bile duct to extrahepatic bile duct. Nippon Shokakibyo Gakkai Zasshi 84: 2597-2602.

Number of references = 77

www psc-literature.org